Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase (original) (raw)

Abstract

Zika virus is an emerging mosquito-borne flavivirus currently causing large epidemics in the Pacific Ocean region and Brazil. Clinically, Zika fever resembles dengue fever, but is less severe. Whereas the clinical syndrome and laboratory diagnostic procedures have been described, little attention was paid to the immunology of the disease and its possible use for clinical follow-up of patients. Here, we investigate the role of cytokines in the pathogenesis of Zika fever in travelers returning from Asia, the Pacific, and Brazil. Polyfunctional T cell activation (Th1, Th2, Th9, and Th17 response) was seen during the acute phase characterized by respective cytokine level increases, followed by a decrease in the reconvalescent phase.

Introduction

Zika virus (ZIKV), a mosquito-borne flavivirus, has lately come to international attention owing to outbreaks on Yap Island, Federated States of Micronesia, in 2007 [1] and in French Polynesia beginning in 2013 [2], and a current epidemic after its recent introduction to Brazil [3]. Both epidemics have been attributed to the Asian genotype of ZIKV [2, 3], likely introduced by viremic travelers. The virus is maintained in a natural cycle involving non-human primates and various Aedes mosquito species [4]. ZIKV causes a self-limiting, dengue fever (DF)-like disease with an incubation time of up to 10 days. Signs and symptoms consist of rather low-grade fever, myalgia and a maculopapular rash, accompanied by arthralgia and headache, and less often edema, sore throat, and vomiting [1–4]. In contrast to DF, acute Zika fever (ZF) is less severe; headache and malaise are less intense and haemorrhagic and shock complications have not been reported. Conjunctivitis is often present, whereas arthralgia is less pronounced [1]. However, unusual rates of Guillain Barré syndrome (GBS) were reported in French Polynesia due to ZIKV infection [5]. Laboratory changes include transient leukopenia and in some cases thrombocytopenia. Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) concentrations may or may not be elevated [6]. Travel-associated infections from both endemic ([6, 7] as examples) and epidemic areas [8, 9] have been documented in non-endemic countries, including the recent report of a patient seen in Italy who became infected in Salvador de Bahia state, Brazil, in the current evolving outbreak.

Whereas the clinical syndrome and laboratory diagnostic procedures, including generic and real-time reverse transcription polymerase chain reactions (RT-PCRs) as well as specific non-commercial serology tests and cross-reactions have been described, little attention was paid to the immunology of the disease and its putative use for clinical follow-up of patients. Here, we analyzed serum cytokine levels of travel-associated infections and demonstrate cytokine concentration changes in acute and recovery (reconvalescent) sera. These changes suggested that strong and multifunctional T cell responses are required for recovery from ZIKV infection.

Patients and methods

Sera from six patients (three males, three females) aged 31–62 years (median 41 years) were used for this study. Patients had acquired ZIKV infection in Southeast Asia, Polynesia, or Brazil. Blood was drawn from infected patients at different times after disease onset (4–62 days). Sera were classified as either acute (taken ≤10 days after symptom onset) or recovery (taken >10 days after disease onset). ZIKV infection was diagnosed serologically, and in one case also molecularly by RT-PCR [8]; see Table 1 for details. From all sera, individual multiplex cytokine serum analyses (Bio-Rad Laboratories, Munich, Germany) were performed and 20 sera from healthy blood donors were run in parallel. Written informed consent was obtained from each patient.

Table 1 Characteristics of patients infected with Zika virus included in the study

Full size table

Results

In the acute phase of ZF, significant concentration elevations were found for interleukin (IL)-1b, IL-2, IL-4, IL-6, IL-9, IL-10, IL-13, IL-17, as well as for interferon-γ-induced protein 10 (IP-10), regulated on activation, normal T cell expressed and secreted (RANTES), macrophage inflammatory protein 1 alpha (MIP-1a) and vascular endothelial growth factor (VEGF), when compared to normal controls. In the recovery phase, significant increases were demonstrated in the levels of IL-1b, IL-6, IL-8, IL-10, IL-13, as well as of IP-10, RANTES, MIP-1a, MIP-1b, and VEGF, fibroblast growth factor (FGF), granulocyte-macrophage colony stimulating factor (GM-CSF), in comparison with healthy controls. Interferon-γ (IFN-γ) levels showed an increasing trend in the acute and recovery phase (non-significant), whereas tumor necrosis factor-α (TNF-α) concentrations only showed a median increase during the acute phase (also non-significant). Many of the cytokines and factors that were elevated in the acute phase showed a tendency to return to normal levels in the later recovery phase (Figs. 1, 2).

Fig. 1

figure 1

Changes in cytokine levels in the acute and recovery phase of Zika fever. With the exception of IL-8, significant elevations of the serum interleukin concentrations are evident in the early, acute phase of Zika fever. In the recovery phase, IL-1b, IL-8, and IL-10 levels were higher than in the acute phase, whereas levels of the other depicted cytokines were declining. Box-and-whisker plots showing median, upper and lower quartile, minimum, and maximum values. *P < 0.05, **P < 0.01, ***P < 0.001, versus healthy controls (Kruskal–Wallis test)

Full size image

Fig. 2

figure 2

Changes in cytokine and growth factor levels in the acute and recovery phase of Zika fever. RANTES, MIP-1a, and VEGF levels were higher in the acute than in the recovery phase, whereas IP-10, MIP-1b, and GM-CSF reached higher concentrations in the recovery phase than during acute infection. IFN-γ levels showed a non-significant, however, increasing trend over the course of infection, whereas TNF-α concentrations only displayed a non-significant median increase in the acute phase. Box-and-whisker plots showing median, upper and lower quartile, minimum, and maximum values. *P < 0.05, **P < 0.01, ***P < 0.001, versus healthy controls (Kruskal–Wallis test)

Full size image

No significant changes, neither in the acute nor in the recovery phase, could be observed for IL-1ra, IL-5, IL-7, IL-12, monocyte chemotactic protein 1 (MCP-1), eotaxin, and platelet-derived growth factor-bb (PDGF-bb; data not shown). There were no significant changes between any of the cytokine levels measured in the acute versus the recovery phase.

Discussion

In contrast to the clinically similar DF, acute ZIKV infections are less severe and secondary infections are not described owing to the fact that only one serotype of ZIKV exists. After an acute ZIKV infection immunity to re-infection is established for an unknown time span, based on epidemiological evidence from past outbreaks [1, 2]. In the patients studied here, elevation of chemokines was more pronounced than elevation of cytokines. In the recovery phase, cytokine levels generally decreased. A polyfunctional immune activation was seen during the acute phase of ZF, as reflected by elevated cytokine profiles associated with Th1 (IL-2, and non-significantly IFN-γ), Th2 (IL-4, IL-13), Th17 (IL-17), and also Th9 (IL-9) responses. Data on IL-9 functions during human viral infection is scarce, but studies have shown an association of elevated IL-9 levels and severe acute respiratory syncytial virus infections [10] and non-response to treatment of chronic hepatitis C [11], suggesting a modulator role of antiviral immunity. In our study, IL-2, IFN-γ and TNF-α levels were surprisingly lower than expected, contrasting with findings in other arboviral infections [12, 13]. Of note, in our study RANTES is already increased in the acute phase, whereas IP-10 is particularly elevated in the recovery phase. Effective T cell recruitment to infection sites and formation of effector T cells was suggested by both increased RANTES and IP-10 concentrations [14, 15]. Since CCR5 and CxCR3 are chemokine ligands receptors for RANTES and IP-10, respectively, immunophenotyping of peripheral blood T cells of ZIKV-infected patients as well as functional T cell assays should help to further explore the role of RANTES and IP-10 during ZF. Similar to descriptions of patients infected with dengue virus (DENV) [16], a related flavivirus, sera of patients with ZF analyzed in our study also showed increased IL-4, IL-6, IL-8, IL-10, and IP-10 levels. IL-10 levels were also highest in the later (recovery) phase of ZIKV infection, as seen in DF [14]. In contrast to DF, however, concentrations of IL-1ß, IL-2, MCP-1, and VEGF were not decreased in ZF patients. In DF, elevated IL-8 and IL-10 levels were shown to be associated with severe infection [14], a clinical state which has so far not been seen in ZF. No “cytokine storm effects”, as known from DENV infections [17] were demonstrated in the ZF patients in our study. Of note, significantly increased IFN-γ and TNF-α levels were absent in ZF in contrast to DF, pointing toward a Th2 bias in ZIKV infections. In DENV infections, thrombocytopenia correlated strongly with RANTES and VEGF levels [16]. Both RANTES, a chemokine stored in a-granules of platelets, secreted upon platelet activation, and VEGF, a growth factor released by platelets, would be expected to decrease upon thrombocytopenia. In contrast, severe thrombocytopenia is rarely observed in ZF patients and RANTES and VEGF did not show decreased levels when compared with the control group. It remains to be elucidated whether ZIKV-induced GBS [5] might be associated with different cytokine responses than changes in non-GBS ZIKV-infected patients.

Due to the small number of ZF patients examined, this study and the strength of the observations are limited. We have analyzed cytokine levels over time in returning travelers to Europe, and it is unknown whether different human ethnic groups might show different cytokine responses as described for DF [18]. Recent ZF epidemics were only caused by the Asian genotype of ZIKV, which is the same genotype also seen in travel-related infections from outbreak areas. Thus, the cytokine data presented here are linked to an infection with the Asian genotype. As a restriction of the study, functional T cell tests (i.e., stimulation with ZIKV antigen followed by intracellular cytokine staining) have not been performed. Future studies will address lymphocyte and cytokine responses in more detail, allowing proper conclusions of Th1- and Th2-biased cell responses. Despite showing rather preliminary data, to our knowledge, this is the first study investigating immune parameters in acute ZF.

References

  1. Duffy MR, Chen TH, Hancock WT et al (2009) Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360:2536–2543
    Article CAS PubMed Google Scholar
  2. Cao-Lormeau VM, Roche C, Teissier A et al (2014) Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 20:1085–1086
    PubMed PubMed Central Google Scholar
  3. Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, Luz K (2015) First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 110:569–572
    Article PubMed PubMed Central Google Scholar
  4. Hayes EB (2009) Zika virus outside Africa. Emerg Infect Dis 15:1347–1350
    Article PubMed PubMed Central Google Scholar
  5. Oehler E, Watrin L, Larre P et al (2014) Zika virus infection complicated by Guillain–Barré syndrome–case report, French Polynesia, December 2013. Euro Surveill 19:20720
    Article PubMed Google Scholar
  6. Tappe D, Rissland J, Gabriel M et al (2014) First case of laboratory-confirmed Zika virus infection imported into Europe, November 2013. Euro Surveill 19:20685
    Article PubMed Google Scholar
  7. Tappe D, Nachtigall S, Kapaun A, Schnitzler P, Günther S, Schmidt-Chanasit J (2015) Acute Zika virus infection after travel to Malaysian Borneo, September 2014. Emerg Infect Dis 21:911–913
    Article PubMed PubMed Central Google Scholar
  8. Zammarchi L, Stella G, Mantella A et al (2015) Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J Clin Virol 63:32–35
    Article PubMed Google Scholar
  9. Zammarchi L, Tappe D, Fortuna C et al (2015) Zika virus infection in a traveller returning to Europe from Brazil. Euro Surveill 20:21153
    Article PubMed Google Scholar
  10. McNamara PS, Flanagan BF, Baldwin LM, Newland P, Hart CA, Smyth RL (2004) Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 363:1031–1037
    Article CAS PubMed Google Scholar
  11. Guzmán-Fulgencio M, Jiménez JL, Berenguer J, Fernández-Rodríguez A, López JC, Cosín J, Miralles P, Micheloud D, Muñoz-Fernández MÁ, Resino S (2012) Plasma IL-6 and IL-9 predict the failure of interferon-α plus ribavirin therapy in HIV/HCV-coinfected patients. J Antimicrob Chemother 67:1238–1245
    Article PubMed Google Scholar
  12. Pang T, Cardosa MJ, Guzman MG (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85:43–45
    Article CAS PubMed Google Scholar
  13. Martina BE (2014) Dengue pathogenesis: a disease driven by the host response. Sci Prog 97:197–214
    Article PubMed Google Scholar
  14. Pandey N, Jain A, Garg RK, Kumar R, Agrawal OP, Lakshmana Rao PV (2015) Serum levels of IL-8, IFN γ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection. Arch Virol 160:1463–1475
    Article CAS PubMed Google Scholar
  15. de-Oliveira-Pinto LM, Marinho CF, Povoa TF, de Azeredo EL, de Souza LA, Barbosa LD, Motta-Castro AR, Alves AM, Ávila CA, de Souza LJ, da Cunha RV, Damasco PV, Paes MV, Kubelka CF (2012) Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. PLoS One 7:e38527
    Article CAS PubMed PubMed Central Google Scholar
  16. Rathakrishnan A, Wang SM, Hu Y et al (2012) Cytokine expression profile of dengue patients at different phases of illness. PLoS One 7:e52215
    Article CAS PubMed PubMed Central Google Scholar
  17. Guabiraba R, Ryffel B (2014) Dengue virus infection: current concepts in immune mechanisms and lessons from murine models. Immunology 141:143–156
    Article CAS PubMed PubMed Central Google Scholar
  18. Restrepo BN, Ramirez RE, Arboleda M, Alvarez G, Ospina M, Diaz FJ (2008) Serum levels of cytokines in two ethnic groups with dengue virus infection. Am J Trop Med Hyg 79:673–677
    CAS PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359, Hamburg, Germany
    Dennis Tappe, Stephan Günther, César Muñoz-Fontela & Jonas Schmidt-Chanasit
  2. German Centre for Infection Research (DZIF), Partner Site Hamburg–Luebeck–Borstel, Hamburg, Germany
    Dennis Tappe, Stephan Günther, César Muñoz-Fontela & Jonas Schmidt-Chanasit
  3. Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
    José Vicente Pérez-Girón, Sergio Gómez-Medina & César Muñoz-Fontela
  4. Clinica Malattie Infettive, Dipartimento di Medicina Sperimentale e Clinica, Università Degli Studi di Firenze, Florence, Italy
    Lorenzo Zammarchi & Alessandro Bartoloni
  5. Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany
    Jürgen Rissland
  6. Institute of Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
    Davis F. Ferreira
  7. Section Clinical Tropical Medicine, Department for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany
    Thomas Jaenisch

Authors

  1. Dennis Tappe
    You can also search for this author inPubMed Google Scholar
  2. José Vicente Pérez-Girón
    You can also search for this author inPubMed Google Scholar
  3. Lorenzo Zammarchi
    You can also search for this author inPubMed Google Scholar
  4. Jürgen Rissland
    You can also search for this author inPubMed Google Scholar
  5. Davis F. Ferreira
    You can also search for this author inPubMed Google Scholar
  6. Thomas Jaenisch
    You can also search for this author inPubMed Google Scholar
  7. Sergio Gómez-Medina
    You can also search for this author inPubMed Google Scholar
  8. Stephan Günther
    You can also search for this author inPubMed Google Scholar
  9. Alessandro Bartoloni
    You can also search for this author inPubMed Google Scholar
  10. César Muñoz-Fontela
    You can also search for this author inPubMed Google Scholar
  11. Jonas Schmidt-Chanasit
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toDennis Tappe.

Ethics declarations

Conflict of interest

All authors declare that they have no conflicts of interest. No author has a commercial or other association that might pose a conflict of interest (e.g., pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding).

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Cite this article

Tappe, D., Pérez-Girón, J.V., Zammarchi, L. et al. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase.Med Microbiol Immunol 205, 269–273 (2016). https://doi.org/10.1007/s00430-015-0445-7

Download citation

Keywords